Caitlin Cronin
Stock Analyst at Canaccord Genuity
(4.11)
# 568
Out of 4,667 analysts
18
Total ratings
54.55%
Success rate
16.7%
Average return
Main Sectors:
Stocks Rated by Caitlin Cronin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCEL Vericel | Maintains: Buy | $60 | $57.26 | +4.79% | 2 | Nov 19, 2024 | |
| KRMD KORU Medical Systems | Maintains: Buy | $3 → $4 | $3.65 | +9.59% | 2 | Nov 14, 2024 | |
| TELA TELA Bio | Maintains: Buy | $12 | $2.90 | +313.79% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 | $9.93 | +101.41% | 3 | Aug 30, 2024 | |
| INMD InMode | Maintains: Hold | $21 → $16 | $18.24 | -12.28% | 2 | Jul 12, 2024 | |
| AXGN Axogen | Reiterates: Buy | $15 | $12.90 | +16.28% | 2 | Jun 20, 2024 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Hold | $130 | $109.27 | +18.97% | 1 | Feb 23, 2024 | |
| ENOV Enovis | Maintains: Buy | $73 → $75 | $44.82 | +67.34% | 1 | Feb 23, 2024 | |
| GMED Globus Medical | Reiterates: Buy | $79 | $83.08 | -4.91% | 1 | Feb 21, 2024 | |
| RBOT Vicarious Surgical | Downgrades: Hold | $270 → $12 | $9.03 | +32.89% | 1 | Nov 14, 2023 |
Vericel
Nov 19, 2024
Maintains: Buy
Price Target: $60
Current: $57.26
Upside: +4.79%
KORU Medical Systems
Nov 14, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $3.65
Upside: +9.59%
TELA Bio
Oct 4, 2024
Maintains: Buy
Price Target: $12
Current: $2.90
Upside: +313.79%
Alphatec Holdings
Aug 30, 2024
Maintains: Buy
Price Target: $20
Current: $9.93
Upside: +101.41%
InMode
Jul 12, 2024
Maintains: Hold
Price Target: $21 → $16
Current: $18.24
Upside: -12.28%
Axogen
Jun 20, 2024
Reiterates: Buy
Price Target: $15
Current: $12.90
Upside: +16.28%
Zimmer Biomet Holdings
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $109.27
Upside: +18.97%
Enovis
Feb 23, 2024
Maintains: Buy
Price Target: $73 → $75
Current: $44.82
Upside: +67.34%
Globus Medical
Feb 21, 2024
Reiterates: Buy
Price Target: $79
Current: $83.08
Upside: -4.91%
Vicarious Surgical
Nov 14, 2023
Downgrades: Hold
Price Target: $270 → $12
Current: $9.03
Upside: +32.89%